First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients

Authors

Institutions

Publication Details

Journal
The Journal of Headache and Pain
Published
2024-09-27
DOI
https://doi.org/10.1186/s10194-024-01873-5
Citations
4
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
1.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients

Xiaoyan Li, Wei Qiao, Shuo Zhu, Peijian Huang et al.
4 citations
The Journal of Headache and Pain
Migraine and Headache Studies
1.54
article

First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients

Xiaoyan Li, Wei Qiao, Shuo Zhu, Peijian Huang, Mengyue Niu, Weihong Yuan, Wenyan Kang, Xiaodan Wang, Jianzhou Yan, Shengyuan Yu, Wenli Xu, Huizhu Zhong, Jun Liu, Yang Zhao
article en
4 citations

Abstract

No abstract available for this paper.
The Journal of Headache and PainVol. 25(1)
China Pharmaceutical University (CN), Ruijin Hospital (CN), Chinese PLA General Hospital (CN), Hainan General Hospital (CN), Qiannan Normal College For Nationalities (CN), Hainan Medical University (CN), Hainan Tropical Ocean University (CN)
Pfizer
Reduced inequalities
Openalex Percentile: Top 16%
Migraine and Headache Studies
1.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.